指南与共识医学教育与科研方法流行病学与生物统计

COVID-19 疫情早期临床指南的范围、质量与包容性:快速综述

Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review.
指南 / 共识 · BMJ · 2020-05-26

该快速综述检索至2020年3月14日的多个数据库,纳入42部COVID-19、MERS和SARS临床指南(其中18部针对COVID-19),用AGREE II评估质量并与近期MERS/SARS指南比较。结果显示早期COVID-19指南细节不足、主题覆盖窄、推荐不一,总体质量差,利益相关者参与、适用性和编辑独立性领域尤其薄弱,对孕妇、儿童和老年人等弱势群体关注极少。

要点

  • 早期COVID-19指南总体质量差,利益相关者参与、适用性和编辑独立性领域薄弱。
  • 指南推荐不一致,例如抗病毒药物使用方面存在差异。
  • 对孕妇、儿童和老年人等弱势群体关注极少。

核心结论

  • COVID-19大流行早期发布的指南存在方法学缺陷,并忽视了老年人等弱势群体。
  • 需要建立公共卫生紧急事件期间临床指南制定框架,以确保方法严谨并纳入弱势人群。

研究设计与样本

  • 快速综述,检索Ovid Medline、Ovid Embase、Ovid Global Health、Scopus、Web of Science Core Collection和WHO Global Index Medicus,从建库至2020年3月14日。
  • 纳入国际和国家科学组织、政府及非政府组织制定的COVID-19、MERS和SARS临床管理指南,无语言限制,排除区域/医院指南,仅纳入最早版本。
  • 共识别2836项研究,筛选后排除2794项,最终纳入42部指南,其中18部针对COVID-19。
  • 使用AGREE II工具评估质量,并将早期COVID-19指南质量与内容与近期MERS和SARS临床指南进行比较。

主要发现

  • 总体而言,临床指南缺乏细节,覆盖主题范围窄。
  • 推荐存在差异,例如抗病毒药物使用方面。
  • 总体质量差,尤其在利益相关者参与、适用性和编辑独立性领域。
  • 证据与推荐之间的联系有限。
  • 对孕妇、儿童和老年人等弱势群体的规定极少。

临床怎么用

  • 临床医生在参考疫情早期指南时需注意其方法学缺陷和推荐不确定性。
  • 应关注弱势群体在指南中的覆盖情况,避免直接套用缺乏细节的推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To appraise the availability, quality, and inclusivity of clinical guidelines produced in the early stage of the coronavirus disease 2019 (covid-19) pandemic. DESIGN: Rapid review. DATA SOURCES: Ovid Medline, Ovid Embase, Ovid Global Health, Scopus, Web of Science Core Collection, and WHO Global Index Medicus, searched from inception to 14 Mar 2020. Search strategies applied the CADTH database guidelines search filter, with no limits applied to search results. Further studies were identified through searches of grey literature using the ISARIC network. INCLUSION CRITERIA: Clinical guidelines for the management of covid-19, Middle East respiratory syndrome (MERS), and severe acute respiratory syndrome (SARS) produced by international and national scientific organisations and government and non-governmental organisations relating to global health were included, with no exclusions for language. Regional/hospital guidelines were excluded. Only the earliest version of any guideline was included. QUALITY ASSESSMENT: Quality was assessed using the Appraisal of Guidelines for Research and Evaluation (AGREE) II tool. The quality and contents of early covid-19 guidelines were also compared with recent clinical guidelines for MERS and SARS. RESULTS: 2836 studies were identified, of which 2794 were excluded after screening. Forty two guidelines were considered eligible for inclusion, with 18 being specific to covid-19. Overall, the clinical guidelines lacked detail and covered a narrow range of topics. Recommendations varied in relation to, for example, the use of antiviral drugs. The overall quality was poor, particularly in the domains of stakeholder involvement, applicability, and editorial independence. Links between evidence and recommendations were limited. Minimal provision was made for vulnerable groups such as pregnant women, children, and older people. CONCLUSIONS: Guidelines available early in the covid-19 pandemic had methodological weaknesses and neglected vulnerable groups such as older people. A framework for development of clinical guidelines during public health emergencies is needed to ensure rigorous methods and the inclusion of vulnerable populations. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42020167361.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Dagens A, Sigfrid L, Cai E, et al. Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review. BMJ. 2020. PMID: 32457027. doi:10.1136/bmj.m1936

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。